Category Specific RSS

HMD

HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use

It may only be a matter of time until expectant mothers can monitor the heartbeats of their unborn child from…

1 year ago

Promising results emerge for HeraMED’s telehealth solution for antenatal care

With the rapid acceleration of telehealth solutions brought about by the pandemic, one company is uniquely servicing a key demographic-…

4 years ago

1 in 4 babies in the US benefit from HeraMed’s pregnancy tech

Medical data and technology company HeraMED (ASX: HMD) has today announced a partnership to accelerate their mission to revolutionise maternal…

4 years ago

High-touch, high-quality maternity care could soon become standard in major hospitals

Bringing telehealth to expectant mothers that will rival major hospital facilities, medtech company HeraMED (ASX: HMD) is taking a significant…

4 years ago

HeraMED to rollout telehealth maternity care in the lucrative U.S market

Prior to COVID-19 bringing attention to the value of telehealth, HeraMED (ASX: HMD) has been building digital infrastructure to revolutionise…

6 years ago

HeraMED shares surge 51% following FDA approval for fetal heart monitor

Medtech company HeraMED (ASX: HMD) has seen a major spike in investor confidence after securing clearance from the US Food…

6 years ago